The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
39
5-substituted difluoropiperidine compounds with blood-brain barrier penetrable capabilityBDB
Wayshine Biopharm Holding
64
MTORC1 modulators and uses thereofBDB
Aeovian Pharmaceuticals
3
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersBDB
Mindset Pharma
145
Amino acid compounds and methods of useBDB
Pliant Therapeutics
9
Use of known compounds as D-amino acid oxidase inhibitorsBDB
National Taiwan University
1
Biochemical binding of RET9 and VEGFR2 inhibitorsBDB
Kala Pharmaceuticals
47
Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitorsBDB
Incyte
68
Imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphataseBDB
University of Alberta
23
Autotaxin inhibitorsBDB
University of Tennessee Research Foundation
427
PD-1/PD-L1 inhibitorsBDB
Gilead Sciences
62
Indole derivative used as CRTH2 inhibitorBDB
Chia Tai Tianqing Pharmaceutical Group
361
Bicyclic-fused heteroaryl or aryl compoundsBDB
Pfizer
26
CaMKII inhibitors and uses thereofBDB
The Johns Hopkins University
3
Quinazolines as potassium ion channel inhibitorsBDB
Bristol Myers Squibb
147
Cyanopyrrolidines as dub inhibitors for the treatment of cancerBDB
Mission Therapeutics
259
2,4-disubstituted pyrimidines useful as kinase inhibitorsBDB
Celgene Car
10
Inhibitors of Bruton's tyrosine kinaseBDB
Hoffmann-La Roche